Functional blocking of Ninjurin1 as a strategy for protecting endothelial cells in diabetes mellitus
Authors:
- 19 January 2018
- journal article
- research article
- Published by Portland Press Ltd. in Clinical Science
- Vol. 132 (2) , 213-229
Abstract
Ongoing efforts to remove pathological inflammatory stimuli are crucial for the protection of endothelial cells in diabetes. Nerve injury-induced protein 1 (Ninj1) is an adhesion molecule that not only contributes to inflammation but also regulates the apoptosis of endothelial cells. In the present study, Ninj1 was found highly expressed in endothelial cells in Type 2 diabetic mice and increased in high-glucose (HG) cultured HUVECs. Furthermore, we found that Ninj1 levels are up-regulated in endothelial cells in clinical specimens of diabetic patients when compared with nondiabetic tissues, indicating a biological correlation between Ninj1 and endothelial pathophysiology in diabetic condition. Functional blocking of Ninj1 promoted endothelial tube formation and eNOS phosphorylation in the HG condition. Additionally, blocking Ninj1 inhibited the activation of caspase-3 and increased the Bcl-2/Bax ratio, thus inhibiting HUVECs apoptosis induced by HG. HG-induced ROS overproduction, p38 MAPK and NF-κB activation, and the overexpression of VCAM-1, ICAM-1, MCP-1, and IL-6 genes were ameliorated after Ninj1 was blocked. Using the signaling pathway inhibitor LY294002, we found that Bcl-2 expression and eNOS phosphorylation after Ninj1 blockade were regulated via PI3K/Akt signaling pathway. The in vivo endothelial contents, α-SMA+PECAM-1+ vascular numbers, and blood perfusion in the hindlimb were markedly up-regulated after Ninj1 was blocked. According to our findings, functional blocking of Ninj1 shows protective effects on diabetic endothelial cells both in vitro and in vivo. Thus, we consider Ninj1 to be a potential therapeutic target for preventing endothelial dysfunction in diabetes mellitus.Keywords
This publication has 49 references indexed in Scilit:
- Nerve Injury-Induced Protein 1 (Ninjurin-1) is a Novel Therapeutic Target for Cavernous Nerve Injury-Induced Erectile Dysfunction in MiceThe Journal of Sexual Medicine, 2013
- Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part IEuropean Heart Journal, 2013
- Glucagon-Like Peptide-1 Protects Against Cardiac Microvascular Injury in Diabetes via a cAMP/PKA/Rho-Dependent MechanismDiabetes, 2013
- Oxidative Stress and Diabetic ComplicationsCirculation Research, 2010
- Ninjurin1 is expressed in myeloid cells and mediates endothelium adhesion in the brains of EAE ratsBiochemical and Biophysical Research Communications, 2009
- Ninjurin1 mediates macrophage-induced programmed cell death during early ocular developmentCell Death & Differentiation, 2009
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesThe Lancet, 2008
- Protective effect of 17β-estradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathwayKidney International, 2008
- Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary ArteriesCirculation, 2003
- Ninjurin, a Novel Adhesion Molecule, Is Induced by Nerve Injury and Promotes Axonal GrowthNeuron, 1996